Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors
- 1 November 2000
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 11 (11) , 1451-1462
- https://doi.org/10.1023/a:1026539908115
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studiesAnnals of Oncology, 1998
- High-dose busulphan/melphalan with autologous stem cell rescue in Ewing’s sarcomaBone Marrow Transplantation, 1997
- The transplantation of hematopoietic stem cells. Part II: Indications after myeloablative therapyMedizinische Klinik, 1997
- T Cells, Graft-versus-Host Disease and Graft-versus-Leukemia: Innovative Approaches for Blood and Marrow TransplantationActa Haematologica, 1996
- Graft-versus-leukemia and graft-versus-lymphoma effects of allogeneic bone marrow transplantation and of allogeneic donor leukocyte transfusionsAnnals of Hematology, 1995
- Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.Journal of Clinical Oncology, 1993
- Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma.Journal of Clinical Oncology, 1993
- Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.Journal of Clinical Oncology, 1993
- Gene-marking to trace origin of relapse after autologous bone-marrow transplantationThe Lancet, 1993
- The Graft Versus Leukemia (GVL) Effect After Allogeneic Bone Marrow Transplantation for Chronic Myelogenous Leukemia (CML)Leukemia & Lymphoma, 1993